Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus?

Francesco Ciodaro, Valentina Katia Mannella, Giovanni Cammaroto, Lilla Bonanno, Francesco Galletti, Bruno Galletti

Research output: Contribution to journalArticlepeer-review

Abstract

The objective of our work is to evaluate recovery induced by gabapentin alone and in association with intradermal infiltration of lidocaine in patients affected by moderate/severe tinnitus. Seventy-two patients suffering from moderate/severe unilateral non-pulsatile subjective tinnitus were enrolled. Severity and behaviour of tinnitus were assessed by Tinnitus handicap Index (THI) on the 8th, 22nd and 36th days from onset of therapy, and on the 3rd and 6th month after the end of therapy in patients treated with oral gabapentin (Group I), oral gabapentin and intradermal injection of lidocaine (Group II), and placebo (Group III) Significant differences in THI scores from the 8th day of therapy to the 22nd (p 

Original languageEnglish
Pages (from-to)2825-2830
Number of pages6
JournalEuropean Archives of Oto-Rhino-Laryngology
Volume272
Issue number10
DOIs
Publication statusPublished - Oct 24 2015

Keywords

  • Gabapentin
  • Lidocaine
  • Tinnitus
  • Tinnitus handicap index

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Oral gabapentin and intradermal injection of lidocaine: is there any role in the treatment of moderate/severe tinnitus?'. Together they form a unique fingerprint.

Cite this